13 citations
,
April 2021 in “Value in Health” There is a significant need for better-validated quality of life tools in dermatology.
4 citations
,
June 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)” A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.
63 citations
,
November 2015 in “Pharmaceutical Sciences” Nanophytosomes can improve the delivery and effectiveness of herbal medicines like Rutin.
April 2024 in “JCT research” February 2016 in “Journal of Allergy and Clinical Immunology” Consider DRIF and perform skin biopsies for persistent papular rashes.
January 2021 in “Universal Journal of Pharmaceutical Research” Russelia equisetiformis extract protects against liver damage from paracetamol.
October 2015 in “Reactions Weekly” A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.
1 citations
,
January 2023 in “PubMed” Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.
3 citations
,
July 2009 in “Experimental and Clinical Endocrinology & Diabetes” Low-dose Buserelin effectively reduces hirsutism with minimal side effects.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Euphorbia hirta oil may promote hair growth naturally.
9 citations
,
February 2021 in “Evidence-based Complementary and Alternative Medicine” Longdan Xiegan decoction is more effective than conventional medicine for treating eczema.
4 citations
,
April 2024 in “Journal of Drugs in Dermatology” Ruxolitinib cream may help treat severe hair loss in children.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is effective long-term for treating alopecia areata in teens.
48 citations
,
July 2023 in “Pediatric Dermatology” Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.
July 2026 in “Dermatology and Therapy” This study compared the effectiveness and safety of baricitinib and ritlecitinib in 160 patients with severe alopecia areata. Both treatments showed similar effectiveness, with 65.5% of baricitinib and 61.5% of ritlecitinib patients achieving a SALT score ≤ 20 by week 52. Eyelash and eyebrow improvements were also comparable between the two groups. Discontinuation due to adverse events was low for both treatments, though non-severe adverse events were more common with baricitinib, primarily due to weight gain. Overall, both medications demonstrated favorable safety profiles and effectiveness, supporting their use in clinical practice for severe alopecia areata.
December 2024 in “Animals” Tithonia diversifolia extract improved digestion but didn't enhance lamb growth.
August 2025 in “Animal nutrition” α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.
8 citations
,
January 2013 in “European Journal of Dermatology” Alitretinoin may help treat alopecia areata.
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” CD101 is highly effective in treating dermatophytosis in guinea pigs.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” 22 citations
,
July 2010 in “Drug Testing and Analysis” A quick method was developed to detect banned substances in urine for doping control.
2 citations
,
November 2025 in “Journal of the American Academy of Dermatology” Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.
63 citations
,
July 2024 in “Journal of the American Academy of Dermatology” Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.
January 2026 in “Journal of Dermatology & Dermatologic Surgery” A 26-year-old male with alopecia universalis, unresponsive to conventional treatments, experienced complete and sustained hair regrowth after taking ruxolitinib, a Janus kinase inhibitor, at 20 mg twice daily. Significant improvement was noted within 12–18 months, with excellent tolerability and no significant adverse events. This case suggests that ruxolitinib is a promising treatment for refractory alopecia universalis, offering potential for hair regrowth and improved quality of life.
June 2016 in “Annals of the Rheumatic Diseases” Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.
11 citations
,
November 2018 in “British Journal of Dermatology” Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.
December 2020 in “Daehanhanuihakoeji” Rumex japonicas Houttuyn ethanol extract helps increase hair growth and protect against hair damage.
January 2025 in “Dermatological Reviews” Cyperus rotundus is a promising natural hair removal option with minimal side effects.
June 2026 in “Drugs in Context” Deucravacitinib effectively treats psoriasis and may help with other skin conditions.